John D. Franzen, MD Fourth-Year Psychiatry Resident, Department of Psychiatry, University of Nebraska Medical Center, Creighton University School of Medicine, Omaha, NE Prasad R. Padala, MD, MS, FACHE Associate Director for Clinical Programs, VISN 16/CAVHS Geriatric Research Education and Clinical Center (GRECC), Associate Professor of Psychiatry, University of Arkansas for Medical Sciences, Little Rock, AR Martin W. Wetzel, MD Assistant Professor, Department of Psychiatry, University of Nebraska Medical Center, Omaha, NE William J. Burke, MD Anna O. Stake Professor of Psychiatry, Vice Chair of Research, Department of Psychiatry, University of Nebraska Medical Center, Omaha, NE
Kessler RC, Adler L, Ames M, et al. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med. 2005;35(2):245-256.
Alexopoulos GS, Salzman C. Treatment of depression with heterocyclic antidepressants, monoamine oxidase inhibitors, and psychomotor stimulants. In: Salzman C, ed. Clinical geriatric psychopharmacology. Baltimore, MD: Williams and Wilkins; 1998:184-244.
Drug Brand Names
Bupropion • Wellbutrin, Zyban
Citalopram • Celexa
Dexmethylphenidate • Focalin
Dextroamphetamine • Dexedrine
Donepezil • Aricept
Lisdexamfetamine • Vyvanse
Methamphetamine • Desoxyn
Methylphenidate • Ritalin, Concerta
Mixed amphetamine salts • Adderall
Warfarin • Coumadin
Disclosures
Dr. Padala receives research funding from the Department of Veterans Health Administration and the Alzheimer’s Association.
Drs. Franzen, Wetzel, and Burke report no financial relationship with any company whose products are mentioned in this article or with manufacturers of competing products.
